| Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma F Audenet, S Isharwal, EK Cha, MTA Donoghue, EN Drill, I Ostrovnaya, ... Clinical Cancer Research 25 (3), 967-976, 2019 | 227 | 2019 |
| Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy. S Gupta, G Sonpavde, CJ Weight, BA McGregor, S Gupta, BL Maughan, ... Journal of Clinical Oncology 38 (6_suppl), 439-439, 2020 | 141 | 2020 |
| Molecular characterization of neuroendocrine-like bladder cancer J Batista da Costa, EA Gibb, TJ Bivalacqua, Y Liu, HZ Oo, DT Miyamoto, ... Clinical cancer research 25 (13), 3908-3920, 2019 | 102 | 2019 |
| 3D printed organ models with physical properties of tissue and integrated sensors K Qiu, Z Zhao, G Haghiashtiani, SZ Guo, M He, R Su, Z Zhu, DB Bhuiyan, ... Advanced materials technologies 3 (3), 1700235, 2018 | 98 | 2018 |
| Biomonitoring DNA adducts of cooked meat carcinogens in human prostate by nano liquid chromatography–high resolution tandem mass spectrometry: identification of 2-amino-1 … S Xiao, J Guo, BH Yun, PW Villalta, S Krishna, R Tejpaul, P Murugan, ... Analytical chemistry 88 (24), 12508-12515, 2016 | 65 | 2016 |
| Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma E Domingo-Musibay, P Murugan, A Giubellino, S Sharma, D Steinberger, ... Journal for Immunotherapy of Cancer 6, 1-7, 2018 | 64 | 2018 |
| Update of the International Consultation on Urological Diseases on bladder cancer 2018: non-urothelial cancers of the urinary bladder S Alanee, I Alvarado-Cabrero, P Murugan, R Kumar, KG Nepple, ... World journal of urology 37, 107-114, 2019 | 62 | 2019 |
| Percentage of sarcomatoid component as a prognostic indicator for survival in renal cell carcinoma with sarcomatoid dedifferentiation M Adibi, AZ Thomas, LD Borregales, MM Merrill, RS Slack, HC Chen, ... Urologic Oncology: Seminars and Original Investigations 33 (10), 427. e17 …, 2015 | 62 | 2015 |
| Immunohistochemical distinction between mesothelial and adenocarcinoma cells in serous effusions: a combination panel-based approach with a brief review of the literature P Murugan, N Siddaraju, S Habeebullah, D Basu Indian journal of pathology and microbiology 52 (2), 175-181, 2009 | 56 | 2009 |
| Which scores need a core? An evaluation of MR-targeted biopsy yield by PIRADS score across different biopsy indications NJ Sathianathen, BR Konety, A Soubra, GJ Metzger, B Spilseth, ... Prostate cancer and prostatic diseases 21 (4), 573-578, 2018 | 48 | 2018 |
| Primary Ewing sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic study of 23 cases P Murugan, P Rao, P Tamboli, B Czerniak, CC Guo Pathology & Oncology Research 24, 153-159, 2018 | 44 | 2018 |
| Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma VL Miller, HK Lin, P Murugan, M Fan, TM Penning, LS Brame, Q Yang, ... International journal of clinical and experimental pathology 5 (4), 278, 2012 | 40 | 2012 |
| Extraosseous Ewing’s sarcoma of the pancreas P Bose, P Murugan, E Gillies, JL Holter International journal of clinical oncology 17, 399-406, 2012 | 36 | 2012 |
| Opposing transcriptional programs of KLF5 and AR emerge during therapy for advanced prostate cancer M Che, A Chaturvedi, SA Munro, SP Pitzen, A Ling, W Zhang, J Mentzer, ... Nature communications 12 (1), 6377, 2021 | 33 | 2021 |
| Associations of socioeconomic status, public vs private insurance, and race/ethnicity with metastatic sarcoma at diagnosis BJ Diessner, BJ Weigel, P Murugan, L Zhang, JN Poynter, LG Spector JAMA Network Open 3 (8), e2011087-e2011087, 2020 | 31 | 2020 |
| BMI1 Drives Metastasis of Prostate Cancer in Caucasian and African-American Men and Is A Potential Therapeutic Target: Hypothesis Tested in Race-specific … AA Ganaie, FH Beigh, M Astone, MG Ferrari, R Maqbool, S Umbreen, ... Clinical Cancer Research 24 (24), 6421-6432, 2018 | 31 | 2018 |
| Hyalinizing clear cell carcinoma of the bronchus M Shahi, M Dolan, P Murugan Head and neck pathology 11, 575-579, 2017 | 31 | 2017 |
| Intratumoral morphologic and molecular heterogeneity of rhabdoid renal cell carcinoma: challenges for personalized therapy RR Singh, P Murugan, LR Patel, H Voicu, SY Yoo, T Majewski, ... Modern Pathology 28 (9), 1225-1235, 2015 | 30 | 2015 |
| Metabolic Activation of the Cooked Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine in Human Prostate M Bellamri, S Xiao, P Murugan, CJ Weight, RJ Turesky Toxicological Sciences 163 (2), 543-556, 2018 | 29 | 2018 |
| Comparative immunomorphology of testicular Sertoli and sertoliform tumors H Mesa, S Gilles, MW Datta, P Murugan, W Larson, S Dachel, JC Manivel Human pathology 61, 181-189, 2017 | 28 | 2017 |
Badrinath KonetyProfessor, Urology, University of MinnesotaPreverjeni e-poštni naslov na umn.edu